Kaleido Biosciences Earnings Estimate

KLDO -  USA Stock  

USD 5.78  0.11  1.94%

Many public companies, such as Kaleido Biosciences, manage the perception of their earnings on regular basis to make sure that analyst estimates are accurate. Future earnings calculations are essential input when attempting to value a firm.
Kaleido Biosciences is projected to generate -2.3775 in earnings per share on 31st of December 2021. Kaleido Biosciences earnings estimates module stress-tests analyst consensus about projected Kaleido Biosciences EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Please see Stocks Correlation.

Search Earnings Estimates 

 
Refresh
The value of Gross Profit is estimated to slide to about 872.4 K. The value of Profit Margin is estimated to slide to -81.29

Kaleido Biosciences Earnings Estimation Breakdown

Calculation of earning per share of Kaleido Biosciences is based on official Zacks consensus of 2 analysts regarding Kaleido Biosciences future annual earnings. Given the historical accuracy of 80.52%, the future earnings per share of Kaleido Biosciences is estimated to be -2.3775 with the lowest and highest values of -2.66 and -2.22, respectively. Please note that this consensus of annual earnings estimates for Kaleido Biosciences is an estimate of EPS before non-recurring items and including employee stock options expenses
Current EPS
-2.38
4th of August 2021
-2.66
Lowest
Estimated EPS
-2.3775
-2.22
Highest

Kaleido Biosciences Earnings Projection Consensus

Suppose the current estimates of Kaleido Biosciences' value are higher than the current market price of the Kaleido Biosciences stock. In this case, investors may conclude that Kaleido Biosciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Kaleido Biosciences' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

2

80.52%

-2.38

-2.3775

Kaleido Biosciences Earnings per Share Projection vs Actual

Actual Earning per Share of Kaleido Biosciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Kaleido Biosciences predict the company's earnings will be in the future. The higher the earnings per share of Kaleido Biosciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Kaleido Biosciences Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Kaleido Biosciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Kaleido Biosciences should always be considered in relation to other companies to make a more educated investment decision.

Kaleido Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Kaleido Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-08-02
2021-06-30-0.57NoneNone
2021-05-04
2021-03-31-0.605-0.580.025
2021-03-03
2020-12-31-0.3984-0.56-0.161640 
2020-11-02
2020-09-30-0.6348-0.65-0.0152
2020-08-04
2020-06-30-0.59-0.590
2020-05-14
2020-03-31-0.6415-0.640.0015
2020-03-02
2019-12-31-0.3366-0.65-0.313493 
2019-10-30
2019-09-30-0.8957-0.740.155717 
2019-08-01
2019-06-30-0.9976-0.830.167616 
2019-05-02
2019-03-31-0.7405-0.680.0605

About Kaleido Biosciences Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Kaleido Biosciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Kaleido Biosciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Kaleido Biosciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2021
Accumulated Retained Earnings Deficit-274.2 M-281.4 M
Earning Before Interest and Taxes EBIT-78.8 M-85 M
Earnings per Basic Share(2.44) (2.63) 
Earnings per Diluted Share(2.44) (2.63) 
Price to Earnings Ratio(3.73) (4.03) 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA-77 M-83.1 M
Earnings before Tax-81.6 M-88.1 M
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts. Kaleido Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Kaleido Biosciences without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Cryptocurrency Center Now

   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Kaleido Biosciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Stocks Correlation. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Kaleido Stock analysis

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
The market value of Kaleido Biosciences is measured differently than its book value, which is the value of Kaleido that is recorded on the company's balance sheet. Investors also form their own opinion of Kaleido Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Kaleido Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kaleido Biosciences' market value can be influenced by many factors that don't directly affect Kaleido Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kaleido Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Kaleido Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kaleido Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.